arrow
C

Chin-Fu Hsiao

國家衛生研究院
H指数:46
被引数:6,821

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic profiling of oropharyngeal squamous cell carcinoma by human papillomavirus status in an Asian cohort: the TCOG T1322 registry study

亚洲队列中根据人乳头瘤病毒状态对人乳头状瘤病毒相关口咽鳞状细胞癌进行基因组分析:TCOG T1322登记研究

2026-11-130
OA
A randomized trial to evaluate the effect of epigallocatechin gallate (EGCG) on EBV reactivation in patients with nasopharyngeal carcinoma in remission -the TCOG T2312 study

一项评估表没食子儿茶素没食子酸酯(EGCG)对处于缓解期的鼻咽癌患者EB病毒再激活影响的随机试验——TCOG T2312研究

2026-10-010
PRE
A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study

用于预测高危GIST患者接受伊马替尼辅助治疗的无复发生存期的列线图:一项全国登记研究

2026-05-010
PRE
A phase I/II study using cabozantinib and lanreotide as treatments for advanced GEP-NETs for which molecular targeted therapy or chemotherapy have failed (SCALET): TCOG T2221 study

I/II期研究使用卡博替尼和兰瑞肽治疗分子靶向治疗或化疗失败的晚期GEP-NETs(SCALET):TCOG T2221研究

2026-01-010
OAAI
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: long-term efficacy and biomarker exploration

Nivolumab联合ipilimumab治疗潜在可切除的肝细胞癌:长期疗效与生物标志物探索

2025-09-170
PREAI
Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study—TCOG T1214 study

台湾地区胃肠胰神经内分泌新生物的临床结局:一项多中心登记研究—TCOG T1214研究

Cancer
IF5.1
2025-08-200
OAAI
Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study
2024-07-110
OAAI
Polygenic Risk Score, Environmental Tobacco Smoke, and Risk of Lung Adenocarcinoma in Never-Smoking Women in Taiwan
2023-11-132
OAAI
Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

东亚地区肺腺癌的全基因组关联研究及与欧洲人群的比较

2023-05-2623
OAAI
Recalibrating Risk Prediction Models by Synthesizing Data Sources: Adapting the Lung Cancer PLCO Model for Taiwan
2022-09-213
OAAI